You can add Asthma, Pneumonia and whatever else you like in there but there are only so many doctors in Australia who will utilise the app.
And even with a license charge GP's aren't going to be wasting too much of their hard earned $$ on license fees when they can alternatively utilise a stethoscope for free.
A hospital may utilise RAP app but has anyone actually done rough numbers on how many patients you would need to utilise RAP on to make RAP reasonably profitable?
- Forums
- ASX - By Stock
- Ann: Positive Results from Australian Adult Clinical Studies
You can add Asthma, Pneumonia and whatever else you like in...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review